Key Financial Data Of Group

SAPPORO CLINICAL LABORATORY INC. - Filing #7247539

Concept As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
20,131,372,000 JPY
17,944,882,000 JPY
17,333,697,000 JPY
19,682,319,000 JPY
17,613,669,000 JPY
20,127,692,000 JPY
17,737,144,000 JPY
19,109,595,000 JPY
16,372,822,000 JPY
17,502,544,000 JPY
Ordinary profit (loss)
707,979,000 JPY
718,706,000 JPY
598,333,000 JPY
514,777,000 JPY
895,308,000 JPY
1,159,449,000 JPY
1,567,931,000 JPY
1,605,618,000 JPY
1,170,964,000 JPY
1,188,144,000 JPY
Profit (loss) attributable to owners of parent
464,176,000 JPY
380,156,000 JPY
568,619,000 JPY
1,042,882,000 JPY
793,688,000 JPY
Comprehensive income
477,654,000 JPY
410,656,000 JPY
649,366,000 JPY
1,019,339,000 JPY
843,471,000 JPY
Net assets
11,394,115,000 JPY
10,869,185,000 JPY
11,183,039,000 JPY
10,640,704,000 JPY
10,212,467,000 JPY
10,880,986,000 JPY
10,337,959,000 JPY
9,839,022,000 JPY
9,272,384,000 JPY
9,014,231,000 JPY
Total assets
16,450,937,000 JPY
15,031,899,000 JPY
16,680,947,000 JPY
15,057,391,000 JPY
14,487,068,000 JPY
16,521,281,000 JPY
16,149,449,000 JPY
14,440,322,000 JPY
14,511,471,000 JPY
13,662,749,000 JPY
Net assets per share
3,575.27
3,484.01
3,283.71
3,194.85
3,066.27
3,178.25
3,016.24
2,934.15
2,708.63
2,633.22
Basic earnings (loss) per share
148.35
152.24
138.25
114.14
141.47
170.53
300.67
306.16
231.10
231.85
Diluted earnings per share
Equity-to-asset ratio
0.678 xbrli:pure
0.723 xbrli:pure
0.656 xbrli:pure
0.707 xbrli:pure
0.705 xbrli:pure
0.641 xbrli:pure
0.626 xbrli:pure
0.681 xbrli:pure
0.639 xbrli:pure
0.660 xbrli:pure
Rate of return on equity
0.042 xbrli:pure
0.044 xbrli:pure
0.044 xbrli:pure
0.035 xbrli:pure
0.047 xbrli:pure
0.055 xbrli:pure
0.109 xbrli:pure
0.108 xbrli:pure
0.092 xbrli:pure
0.090 xbrli:pure
Price-earnings ratio
6.61 xbrli:pure
6.44 xbrli:pure
7.86 xbrli:pure
9.51 xbrli:pure
8.96 xbrli:pure
7.43 xbrli:pure
4.31 xbrli:pure
4.23 xbrli:pure
6.63 xbrli:pure
6.61 xbrli:pure
Net cash provided by (used in) operating activities
730,911,000 JPY
1,077,593,000 JPY
1,430,350,000 JPY
1,573,628,000 JPY
837,590,000 JPY
Net cash provided by (used in) investing activities
-1,240,168,000 JPY
-395,474,000 JPY
-409,028,000 JPY
-830,960,000 JPY
-3,148,264,000 JPY
Net cash provided by (used in) financing activities
-525,743,000 JPY
-369,961,000 JPY
-347,894,000 JPY
-112,738,000 JPY
1,943,634,000 JPY
Cash and cash equivalents
2,931,206,000 JPY
3,966,205,000 JPY
3,654,048,000 JPY
2,980,620,000 JPY
2,350,691,000 JPY
Number of employees
3 xbrli:pure
533 xbrli:pure
315 xbrli:pure
303 xbrli:pure
21 xbrli:pure
19 xbrli:pure
879 xbrli:pure
303 xbrli:pure
3 xbrli:pure
642 xbrli:pure
21 xbrli:pure
871 xbrli:pure
635 xbrli:pure
627 xbrli:pure
938 xbrli:pure
871 xbrli:pure
622 xbrli:pure
819 xbrli:pure
775 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.